The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.
-
Upload
paul-baker -
Category
Documents
-
view
220 -
download
3
description
Transcript of The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.
![Page 1: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/1.jpg)
The Pain Market:
Spain Core Therapeutic ReportNational Health and Wellness Survey 2010
![Page 2: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/2.jpg)
2
Method and Sample
Data Collection+ Survey administered via the Internet since 2002+ Data collected during March-May 2010+ Countries: Spain
Sample+ Adults 18+ years of age+ Sample drawn from the Internet panel maintained by Lightspeed Research+ Invitations to participate sent to a sample stratified according to:
– Gender– Age
Results are projected to reflect the total population using known population incidences for key subgroups
+ Weighting Variables: Gender and age+ From the International Data Base of the U.S. Census Bureau and
Organization for Economic Cooperation and Development
![Page 3: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/3.jpg)
3
Sample Spain Population
(n)Projected Number of
Spain AdultsTotal Spain Adults 5,039 35.4 MExperiencing Pain (in the past month)* 868 6.1 MSevere 100 714 K
Moderate 554 3.9 M
Mild 214 1.5 M
Severe:Rx 81 572 K
OTC‡ Only 10†† 73 K
Untreated 9†† 68 K
Moderate:Rx 357 2.6 M
OTC‡ Only 106 710 K
Untreated 91 622 K
Mild:Rx 77 551 K
OTC‡ Only 81 549 K
Untreated 56 374 K
Spain Sample Size
Key segments of the Pain market are represented by the following sample sizes:
††Caution: extremely small base size ‡OTC/Herbal Products*Excludes dental problems, headache, menstrual pain or migraine only.
![Page 4: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/4.jpg)
Spain Pain Prevalence 2010
4††Base too small to project to total population (n<15) ‡OTC/Herbal ProductsQuestions reference for this slide include: HH10, HH20, PN5, PN15, PN20, PN95, PN120, DB40 (See Appendix)
*Excludes dental problems, headache, menstrual pain or migraine only.
Experiencing Pain (in the past month)*
6.1 M (17%)(n=868)
SEVERE714 K (12%)
(n=100)
Use Rx572 K 80%
(n=81)
OTC‡ Only73 K 10%
(n=10††)
Untreated68 K 10%
(n=9††)
MODERATE3.9 M (64%)
(n=554)
Use Rx2.6 M 66%
(n=357)
OTC‡ Only710 K 18%
(n=106)
Untreated622 K 16%
(n=91)
MILD1.5 M (24%)
(n=214)
Use Rx551 K 37%
(n=77)
OTC‡ Only549 K 37%
(n=81)
Untreated374 K 25%
(n=56)
Total Spain Adults Population
35.4 M(n=5,039)
![Page 5: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/5.jpg)
All OTC‡ Users191 K (27%)
(n=26†)
Total Use Rx572 K 80%
(n=81)
Spain Pain Brand Usage 2010
Experiencing Pain (in the past month)*6.1 M (17%) (n=868)
SEVERE714 K (12%)
(n=100)
*Excludes dental problems, headache, menstrual pain or migraine only.‡OTC/Herbal Products†Caution: small base (n<30)††Base too small to project to total population (n<15) Questions reference for this slide include: HH10, HH20, PN5, PN15, PN20, PN30, PN95, PN100, PN120 , DB40 (See Appendix)
5
Specific Rx Therapies Used(By Class of Drug)
Strong Opioids †† (n=12†) Weak Opioids 294 K 51% (n=39) NSAIDs 362 K 63% (n=52) COX-2s †† (n=7†) Anticonvulsants 155 K 27% (n=23†) Amitriptyline †† (n=0†) Analgesics †† (n=14†) All Other Pain Medications †† (n=4†)
Top OTC‡ Therapies Used(Unaided)
Ibuprofen Products †† (n=13†) Acetaminophen /Paracetamol †† (n=2†) Aspirin Products †† (n=0†)Diclofenac †† (n=0†) Others(inc. combination OTCs‡) †† (n=10†)
MODERATE3.9 M (64%)
(n=554)
Total Use Rx2.6 M 66%
(n=357)
Total OTC‡ Users 1.3 M (32%)
(n=180)
MILD1.5 M (24%)
(n=214)
Total Use Rx551 K 37%
(n=77)
Total OTC‡ Users 620 K (42%)
(n=91)
Specific Rx Therapies Used(By Class of Drug)
Strong Opioids †† (n=3†) Weak Opioids 1.1 M 43% (n=143) NSAIDs 1.8 M 71% (n=261) COX-2s 126 K 5% (n=20†) Anticonvulsants 245 K 10% (n=34) Amitriptyline †† (n=0†) Analgesics 351 K 14% (n=55) All Other Pain Medications †† (n=13†)
Specific Rx Therapies Used(By Class of Drug)
Strong Opioids †† (n=0†) Weak Opioids 126 K 23% (n=18†) NSAIDs 418 K 76% (n=60) COX-2s †† (n=2†) Anticonvulsants †† (n=2†) Amitriptyline †† (n=0†) Analgesics †† (n=5†) All Other Pain Medications †† (n=3†)
Top OTC‡ Therapies Used(Unaided)
Ibuprofen Products 824 K 66% (n=124) Acetaminophen /Paracetamol 406 K 32% (n=59) Aspirin Products 187 K 15% (n=23†)Diclofenac †† (n=5†) Others(inc. combination OTCs‡) 621 K 50% (n=93)
Top OTC‡ Therapies Used(Unaided)
Ibuprofen Products 392 K 63% (n=59) Acetaminophen /Paracetamol 167 K 27% (n=26†) Aspirin Products 128 K 21% (n=18†)Diclofenac †† (n=3†) Others(inc. combination OTCs‡) 292 K 47% (n=44)
Total Spain Adults Population35.4 M (n=5,039)
![Page 6: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/6.jpg)
6
Experiencing Pain in Past Month*
Total Rx Users
Strong Opioids
Weak Opioids NSAIDs COX-2s
AntiConv-ulsants
Amitri-ptyline Analgesics
All Other Pain
Medication3.7 M 125 K 1.5 M 2.6 M 182 K 412 K 0 K 488 K 144 K
(n=515) (n=15†) (n=200) (n=373) (n=29†) (n=59) (n=0††) (n=74) (n=20†)
Duration of Rx Usage (mean # of months)Experiencing Pain (in the past month)* 67.8 26.7 59.3 68.8 33.2 33.4 - 64.1 65.5Severe 81.1 32.6 79.7 92.3 57.3 40.5 - 55.3 94.5Moderate 69.9 7.5 57.1 69.4 26.9 30.2 - 69.5 44.0Mild 44.4 - 31.7 46.1 7.1 9.4 - 33.5 93.9% Extremely/Very SatisfiedExperiencing Pain (in the past month)* 40% 31% 31% 43% 37% 46% - 45% 52%Severe 32% 39% 29% 28% 31% 33% - 28% 79%Moderate 40% - 32% 43% 40% 51% - 47% 23%Mild 55% - 21% 59% 31% 100% - 84% 100%# Days/Mo. Report Taking Rx (mean)Experiencing Pain (in the past month)* 16 21 15 12 13 24 - 16 16Severe 23 21 20 18 15 25 - 18 19Moderate 16 20 14 12 14 24 - 16 20Mild 8 - 8 7 8 15 - 14 4% Requested Specific RxExperiencing Pain (in the past month)* 29% 25% 26% 28% 14% 11% - 29% 26%Severe 27% 24% 30% 26% 17% 16% - 33% 46%Moderate 28% 26% 22% 27% 10% 9% - 27% 24%Mild 36% - 45% 35% 44% - - 40% 17%
Pain Prescription Medication Usage
Pain Prescription Medication Usage(Experiencing Pain and using Rx)*
*Excludes dental problems, headache, menstrual pain or migraine only. Caution: †small base size; ††extremely small base size*Note: mean satisfaction taken into consideration if multiple pain therapies are used.PN35: You indicated you use the following prescription medication(s). Did you request this specific brand from your doctor?.PN40: How many years and/or months have you been using these prescription medication(s)? If you have been using it less than 1 month, please enter a “0” for ”years” and “1” for “months”.PN45: How many days did you use these prescription medication(s) in the past month?PN50: How satisfied are you with these prescription medication(s)?Based on 7 point scale where 1=Extremely dissatisfied and 7=Extremely satisfied In 2010, a "stacked" method was used for determining overall medication satisfaction
![Page 7: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/7.jpg)
Comparison of SF-12v2 Physical/Mental Health Scores by Subgroups to Total Population Score
7
‡OTC/Herbal Products Caution: extremely small base size *Excludes dental problems, headache, menstrual pain or migraine only.General Health - summary scores.Letters indicate statistically significant difference @ 95% confidence level between subgroups
Physical Health Summary Mental Health Summary
Spain Total Population Score Mean=48.4
Total Spain Adults(35.4 M; n=5,039)
Experiencing Pain (in the past month)*(6.1 M; n=868)
Severe (C)
(714 K; n=100)
Mild (E)
(1.5 M; n=214)
Moderate (D)
(3.9 M; n=554)
Expe
rienc
ing
Pain
(in
the
past
mon
th)*
Rx (L)
(551 K; n=77)OTC‡ Only (M)
(549 K; n=81)Untreated (N)
(374 K; n=56)
Seve
re:
Spain Total Population Score Mean=47.4
C
Rx (F)
(572 K; n=81)OTC‡ Only (G)
(73 K; n=10)Untreated (H)
(68 K; n=9)Rx (I)
(2.6 M; n=357)OTC‡ Only (J)
(710 K; n=106)Untreated (K)
(622 K; n=91)Mod
erat
e:M
ild:
CD
I
I
L
C
CD
![Page 8: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/8.jpg)
8
Pain Interfered With Normal Work During The Past 4 Weeks
Total Spain Adults
Exp. Pain (in the past
month)*
Experiencing Pain (in the past month)* Severe Moderate Mild
Severe (C)
Moderate(D)
Mild(E)
Rx(F)
OTC‡ Only(G)
Untr-eated
(H)Rx(I)
OTC‡ Only(J)
Untr-eated
(K)Rx(L)
OTC‡ Only(M)
Untr-eated
(N)35.4 M 6.1 M 714 K 3.9 M 1.5 M 572 K 73 K 68 K 2.6 M 710 K 622 K 551 K 549 K 374 K
(n=5,039) (n=868) (n=100) (n=554) (n=214) (n=81) (n=10) (n=9) (n=357) (n=106) (n=91) (n=77) (n=81) (n=56)General HealthExtremely 2% 6% 35%DE 2% 0% 34% 30% 53% 3% 2% - 1% - - Quite a bit 8% 23% 48%DE 26%E 4% 52% 34% 26% 32%JK 15% 15% 5% 4% 2%Moderately 17% 27% 13% 31%CE 22% 11% 27% 11% 32% 27% 31% 28% 16% 19%A little bit 32% 36% 4% 34%C 58%CD 3% 9% 10% 30% 40% 42%I 57% 61% 56%No at all 42% 8% - 7% 16%D - - - 3% 16%I 11%I 9% 19% 23%L
Pain Interfered With Normal Work During The Past 4 Weeks
‡OTC/Herbal Products Caution: extremely small base size Zero % implies a very small value less than 0.5%*Excludes dental problems, headache, menstrual pain or migraine only. GH25: During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)?(1-5 Scale: 1=Excellent and 5=No at all)Letters indicate statistically significant difference @ 95% confidence level between subgroups
![Page 9: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/9.jpg)
9
Physical Health Or Emotional Problems Interfered With Social Activities During The Past 4 Weeks
Total Spain Adults
Exp. Pain (in the past
month)*
Experiencing Pain (in the past month)* Severe Moderate Mild
Severe (C)
Moderate(D)
Mild(E)
Rx(F)
OTC‡ Only(G)
Untr-eated
(H)Rx(I)
OTC‡ Only(J)
Untr-eated
(K)Rx(L)
OTC‡ Only(M)
Untr-eated
(N)35.4 M 6.1 M 714 K 3.9 M 1.5 M 572 K 73 K 68 K 2.6 M 710 K 622 K 551 K 549 K 374 K
(n=5,039) (n=868) (n=100) (n=554) (n=214) (n=81) (n=10) (n=9) (n=357) (n=106) (n=91) (n=77) (n=81) (n=56)General HealthAll of the time 2% 4% 24%DE 2% 1% 27% 8% 11% 3% - 1% - 3% - Most of the time 8% 13% 29%DE 12%E 7% 30% 27% 18% 14% 8% 10% 10% 5% 7%Some of the time 19% 27% 28% 29% 22% 26% 38% 28% 34%JK 23% 16% 22% 20% 26%A little of a time 30% 30% 13% 31%C 36%C 14% 17% - 28% 34% 42%I 42% 38% 25%None of the time 41% 25% 7% 24%C 33%CD 3% 9% 42% 20% 35%I 32%I 26% 34% 42%
Physical Health Or Emotional Problems Interfered WithSocial Activities During The Past 4 Weeks
‡OTC/Herbal Products Caution: extremely small base size *Excludes dental problems, headache, menstrual pain or migraine only. GH35: During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? (1-5 Scale: 1=all of the time and 5=None of the time)Letters indicate statistically significant difference @ 95% confidence level between subgroups
![Page 10: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/10.jpg)
10
‡OTC/Herbal Products ^Differing base size Caution: extremely small base size *Excludes dental problems, headache, menstrual pain or migraine only. All the figures are for presently Full Time employees apart from activity impairmentDE30: What is your employment status?WPPCTWRK: Percentage work time missed due to health. WPIMPAIR: Percentage impairment while working due to health.WPWRKIMP: Percentage overall work impairment due to health. WPACTIMP: Percentage activity impairment due to health.(0-10 Scale: 0=health problems had no effect on my work and 10=health problems completely prevented me from working)Letters indicate statistically significant difference @ 95% confidence level between subgroups
Spain Adult Work Productivity and Activity Impairment
Total Spain Adults
Exp. Pain (in the past
month)*
Experiencing Pain (in the past month)* Severe Moderate Mild
Severe (C)
Moderate(D)
Mild(E)
Rx(F)
OTC‡ Only(G)
Untr-eated
(H)Rx(I)
OTC‡ Only(J)
Untr-eated
(K)Rx(L)
OTC‡ Only(M)
Untr-eated
(N)35.4 M 6.1 M 714 K 3.9 M 1.5 M 572 K 73 K 68 K 2.6 M 710 K 622 K 551 K 549 K 374 K
(n=5,039) (n=868) (n=100) (n=554) (n=214) (n=81) (n=10) (n=9) (n=357) (n=106) (n=91) (n=77) (n=81) (n=56)Employed full time 37% 34% 20% 33%C 45%CD 25% - - 29% 43%I 37% 41% 50% 44%Absenteeism^% work time missed due to health – past 7 days (mean)
4.6 12.7 41.8DE 12.8 6.3 41.8 - - 17.7J 2.3 11.2 7.1 5.7 6.1
Presenteeism^% impairment while working due to health (mean)
17.1 25.1 38.3 25.4 22.9 38.3 - - 28.6 21.1 22.1 25.2 21.4 22.3
Work Productivity Loss^% overall work impairment due to health (mean)
20.1 33.6 62.8DE 33.9 26.6 62.8 - - 40.1J 21.4 30.5 29.6 24.4 26.3
Activity Impairment% activity impairment due to health (mean)
25.6 41.7 74.4DE 41.6E 26.0 79.2 61.5 47.7 47.2JK 27.0 35.2J 30.6N 24.9 20.9
Spain Adult Work Productivity and Activity Impairment
![Page 11: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/11.jpg)
61%
40%
29%
35%
17%
12%
10%
10%
23%
7%
Type of Pain Conditions
11*Excludes dental problems, headache, menstrual pain or migraine only.PN15: Please indicate which of the following conditions have caused you to feel pain in the past month.Letters indicate statistically significant difference @ 95% confidence level between subgroups
Pain population, prevalence of conditions causing pain by pain severity(Respondents with pain in the past month)
Experience Pain(in the past month)*
(6.1 M; n=868)Moderate (D)
(3.9 M; n=554)Mild (E)
(1.5 M; n=214)
Experiencing Pain (in the past month)*
Back pain
Headache
Shoulder pain/stiffness
Arthritis pain
Neck pain
Migraine
Dental pain
Sprains or strains
Surgery or medical procedure
Joint pain
13%
15%
15%
12%
17%
28%
15%
13%
16%
29%
67%
66%
66%
64%
66%
57%
71%
57%
67%
63%
19%
19%
19%
24%
16%
15%
14%
31%
17%
8%
Severe (C)
(714 K; n=100)
![Page 12: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/12.jpg)
12
Experience Symptoms/Side Effects – Among Rx Opioid Users
Experience Symptoms/Side Effects – Among Rx Opioid Users(Respondents with pain in the past month (qualified respondents), taking opioid medications, experiencing symptoms)
Nausea
Experience Pain(in the past month)*
(239 K; n=37)Severe (C)
(77 K; n=12††)Moderate (D)
(149 K; n=23†)Mild (E)
(13 K; n=2††)
Experiencing Pain (in the past month)*
Abdominal pain / discomfort
Dizziness
Constipation
Sleepiness
Trouble thinking clearly
Other digestive symptoms
Vomiting
Feeling moody, irritable, anxious, or restless
Diarrhea
Bloating
Other
None of above
Caution: †small base size; ††extremely small base size *Excludes dental problems, headache, menstrual pain or migraine only.PN60: Please indicate the symptoms you experience while taking <insert name(s) of opioid medication> for your pain?No statistically significant difference @ 95% confidence level between subgroups
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
![Page 13: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.](https://reader036.fdocuments.in/reader036/viewer/2022062503/5a4d1ae27f8b9ab059977e72/html5/thumbnails/13.jpg)
13
CONTACT INFORMATION Global Headquarters
Kantar Health Health Sciences Practice1 Independence Way, Suite 220, Princeton, NJ 08540Telephone: +1 (609) 720 5480 Fax: +1 (609) 720 5481
11 Madison Avenue, 12th Floor, New York, NY 10010 Telephone: +1 (212) 706 4279 Fax: +1 (212) 647 7659
Spain NHWS 2010 Data
When referencing data from this report please use the following citation:
+ Kantar Health. September 2010. NATIONAL HEALTH AND WELLNESS SURVEY, 2010 [Spain]. Princeton, NJ.